BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 7828344)

  • 1. Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours.
    Pascale MM; Pugeat M; Roberts M; Rousset H; Déchaud H; Dutrieux-Berger N; Tourniaire J
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):571-6. PubMed ID: 7828344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction.
    Cedars MI; Steingold KA; de Ziegler D; Lapolt PS; Chang RJ; Judd HL
    Fertil Steril; 1992 Mar; 57(3):495-500. PubMed ID: 1531463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperthecosis ovarii--a tumor-like change in androgenized females].
    Schwartz U; Moltz L; Pickartz H; Sörensen R; Römmler A
    Geburtshilfe Frauenheilkd; 1986 Jun; 46(6):391-7. PubMed ID: 3091442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid secretory characteristics of a virilizing adrenal adenoma in a woman.
    Bradshaw KD; Milewich L; Mason JI; Parker CR; MacDonald PC; Carr BR
    J Endocrinol; 1994 Feb; 140(2):297-307. PubMed ID: 8169562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a long-acting gonadotropin-releasing hormone analog on the pituitary-ovarian-adrenal axis in women with severe hirsutism.
    Castelo-Branco C; Martínez de Osaba MJ; Martínez S; Fortuny A
    Metabolism; 1996 Jan; 45(1):24-7. PubMed ID: 8544772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion.
    Lanzone A; Fulghesu AM; Guido M; Fortini A; Caruso A; Mancuso S
    Fertil Steril; 1992 Aug; 58(2):296-301. PubMed ID: 1321739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An unusual steroid-producing ovarian tumour: case report.
    Stephens JW; Katz JR; McDermott N; MacLean AB; Bouloux PM
    Hum Reprod; 2002 Jun; 17(6):1468-71. PubMed ID: 12042263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A gonadotrophin dependent stromal luteoma: a rare cause of post-menopausal virilization.
    Chico A; García JL; Matías-Guiu X; Webb SM; Rodríguez J; Prat J; Calaf J
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):645-9. PubMed ID: 8548951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome.
    Gonzalez F; Hatala DA; Speroff L
    Am J Obstet Gynecol; 1991 Sep; 165(3):535-45. PubMed ID: 1832519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adrenal cortex and virilization.
    McKenna TJ; Cunningham SK; Loughlin T
    Clin Endocrinol Metab; 1985 Nov; 14(4):997-1020. PubMed ID: 3002682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?
    Escobar-Morreale HF; Serrano-Gotarredona J; García-Robles R; Sancho J; Varela C
    Metabolism; 1997 Aug; 46(8):902-7. PubMed ID: 9258272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease.
    Toscano V; Balducci R; Bianchi P; Mangiantini A; Sciarra F
    J Clin Endocrinol Metab; 1990 Aug; 71(2):288-92. PubMed ID: 2166066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease.
    Steingold K; De Ziegler D; Cedars M; Meldrum DR; Lu JK; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1987 Oct; 65(4):773-8. PubMed ID: 3116031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pure Leydig cell tumour (hilus cell) of the ovary: a rare cause of virilization after menopause.
    Baiocchi G; Manci N; Angeletti G; Celleno R; Fratini D; Gilardi G
    Gynecol Obstet Invest; 1997; 44(2):141-4. PubMed ID: 9286731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virilizing adrenal adenoma in an adult with the Beckwith-Wiedemann syndrome: paradoxical response to dexamethasone.
    Clouston WM; Cannell GC; Fryar BG; Searle JW; Martin NI; Mortimer RH
    Clin Endocrinol (Oxf); 1989 Oct; 31(4):467-73. PubMed ID: 2534067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic GnRH analogue administration on gonadotrophin and alpha-subunit secretion in post-menopausal women.
    Oppenheim DS; Bikkal H; Crowley WF; Klibanski A
    Clin Endocrinol (Oxf); 1992 Jun; 36(6):559-64. PubMed ID: 1385024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of androgens in the regulation of the human menstrual cycle.
    Rossmanith WG; Schenkel B; Benz R
    Gynecol Endocrinol; 1994 Sep; 8(3):151-9. PubMed ID: 7847099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How do androgens affect episodic gonadotrophin secretion in postmenopausal women?
    Rossmanith WG; Beuter M; Benz R; Lauritzen C
    Maturitas; 1991 Oct; 13(4):325-35. PubMed ID: 1775085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.